The efficacy of biologic or conventional systemic therapies for psoriasis has been shown in randomized controlled trials. Effectiveness, however, has been studied in daily practice cohorts, and no aggregation of effectiveness data is available. This systematic review searched PubMed and EMBASE and summarized the real-world evidence on effectiveness of biologics (adalimumab, etanercept, infliximab and ustekinumab) and conventional systemic therapies (acitretin, cyclosporine, fumarates and methotrexate) for the treatment of plaque psoriasis in adults. Thirty-two studies were included. Few data were available on infliximab, ustekinumab and conventional systemics. Results show that biologics and conventional systemics were effective in real-lif...
The majority of people with psoriasis have localized disease, where topical therapy forms the corner...
OBJECTIVES: While off-label dosing of biologic treatments may be necessary in selected psoriasis pat...
Abstract Introduction Deucravacitinib, a newly approved oral medication for the treatment of patient...
Contains fulltext : 172420.pdf (publisher's version ) (Open Access)The efficacy of...
Chronic plaque psoriasis is an immune-mediated, inflammatory skin disease with a heavy burden on qua...
AbstractTo perform a systematic review and meta-analysis of randomized controlled trials (RCT’s) rep...
Chronic plaque psoriasis is an immune-mediated, inflammatory skin disease with a heavy burden on qua...
IntroductionNew generation biologics, including interleukin (IL)-17 and IL-23 inhibitors, have deliv...
Alefacept, efalizumab, etanercept, and infliximab are currently approved for the treatment of adults...
This review focuses on the emerging concepts concerning the efficacy profile of biological drugs in ...
OBJECTIVE: To compare the effectiveness of biologic systemic therapy, nonbiologic systemic therapy, ...
BACKGROUND: Ustekinumab, a novel monoclonal antibody for the treatment of moderate to severe plaque-...
Background: Psoriasis continues to have unmet needs in its management despite introduction of newer ...
Background: Advancements in medicine development have made available novel therapies that are improv...
BACKGROUND: The efficacy of etanercept and ustekinumab in psoriasis has been compared in one randomi...
The majority of people with psoriasis have localized disease, where topical therapy forms the corner...
OBJECTIVES: While off-label dosing of biologic treatments may be necessary in selected psoriasis pat...
Abstract Introduction Deucravacitinib, a newly approved oral medication for the treatment of patient...
Contains fulltext : 172420.pdf (publisher's version ) (Open Access)The efficacy of...
Chronic plaque psoriasis is an immune-mediated, inflammatory skin disease with a heavy burden on qua...
AbstractTo perform a systematic review and meta-analysis of randomized controlled trials (RCT’s) rep...
Chronic plaque psoriasis is an immune-mediated, inflammatory skin disease with a heavy burden on qua...
IntroductionNew generation biologics, including interleukin (IL)-17 and IL-23 inhibitors, have deliv...
Alefacept, efalizumab, etanercept, and infliximab are currently approved for the treatment of adults...
This review focuses on the emerging concepts concerning the efficacy profile of biological drugs in ...
OBJECTIVE: To compare the effectiveness of biologic systemic therapy, nonbiologic systemic therapy, ...
BACKGROUND: Ustekinumab, a novel monoclonal antibody for the treatment of moderate to severe plaque-...
Background: Psoriasis continues to have unmet needs in its management despite introduction of newer ...
Background: Advancements in medicine development have made available novel therapies that are improv...
BACKGROUND: The efficacy of etanercept and ustekinumab in psoriasis has been compared in one randomi...
The majority of people with psoriasis have localized disease, where topical therapy forms the corner...
OBJECTIVES: While off-label dosing of biologic treatments may be necessary in selected psoriasis pat...
Abstract Introduction Deucravacitinib, a newly approved oral medication for the treatment of patient...